COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 51,977 | 481,848 | SH | | OTR | | 481,848 | 0 | 0 |
ACCELERON PHARMA INC | COM | 00434H108 | 372,539 | 2,164,663 | SH | | OTR | | 2,164,663 | 0 | 0 |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 3,506 | 450,000 | SH | | OTR | | 450,000 | 0 | 0 |
AGILE GROWTH CORP | CLASS A ORD | G01202103 | 11,664 | 1,200,000 | SH | | OTR | | 1,200,000 | 0 | 0 |
AGILE GROWTH CORP | *W EXP 03/09/202 | G01202111 | 254 | 399,999 | SH | | OTR | | 399,999 | 0 | 0 |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 37,786 | 818,767 | SH | | OTR | | 818,767 | 0 | 0 |
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 62,388 | 421,400 | SH | | OTR | | 421,400 | 0 | 0 |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 153,748 | 814,301 | SH | | OTR | | 814,301 | 0 | 0 |
ALPHA CAPITAL ACQUISITION CO | CL A ORD SHS | G0316P130 | 774 | 79,598 | SH | | OTR | | 79,598 | 0 | 0 |
ALPHA CAPITAL ACQUISITION CO | *W EXP 02/16/202 | G0316P122 | 22 | 39,799 | SH | | OTR | | 39,799 | 0 | 0 |
ALPHABET INC | CAP STK CL C | 02079K107 | 480,974 | 180,457 | SH | | OTR | | 180,457 | 0 | 0 |
AMYRIS INC | COM NEW | 03236M200 | 160,901 | 11,718,925 | SH | | OTR | | 11,718,925 | 0 | 0 |
ANNEXON INC | COM | 03589W102 | 21,537 | 1,157,261 | SH | | OTR | | 1,157,261 | 0 | 0 |
ANTHEM INC | COM | 036752103 | 318,731 | 854,965 | SH | | OTR | | 854,965 | 0 | 0 |
AON PLC | SHS CL A | G0403H108 | 360,732 | 1,262,315 | SH | | OTR | | 1,262,315 | 0 | 0 |
APOLLO STRATEGIC GRWT CPTL II | SHS CL A | G0412A102 | 7,328 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
APOLLO STRATEGIC GRWT CPTL II | *W EXP 02/12/202 | G0412A128 | 140 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
ARAMARK | COM | 03852U106 | 601,918 | 18,317,656 | SH | | OTR | | 18,317,656 | 0 | 0 |
ARCLIGHT CLEAN TRANSITION II | CLASS A ORD SHS | G0R21B104 | 7,320 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
ARCLIGHT CLEAN TRANSITION II | *W EXP 03/16/202 | G0R21B112 | 164 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
ARCTOS NORTHSTAR ACQUIS CORP | SHS CL A | G0477L100 | 1,950 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
ARCTOS NORTHSTAR ACQUIS CORP | *W EXP 99/99/999 | G0477L126 | 37 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 39,097 | 656,548 | SH | | OTR | | 656,548 | 0 | 0 |
ARES ACQUISITION CORPORATION | *W EXP 99/99/999 | G33032122 | 170 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
ARES ACQUISITION CORPORATION | COM CL A | G33032106 | 9,740 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 49,730 | 796,578 | SH | | OTR | | 796,578 | 0 | 0 |
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 8,048 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
ARYA SCIENCES ACQUISITN CORP V | CLASS A ORD SHS | G31658100 | 7,361 | 745,000 | SH | | OTR | | 745,000 | 0 | 0 |
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 20,060 | 334,000 | SH | | OTR | | 334,000 | 0 | 0 |
ATENTO S A | SHS | L0427L204 | 62,918 | 2,230,357 | SH | | OTR | | 2,230,357 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP I | SHS CL A | G0633D109 | 24,421 | 2,456,887 | SH | | OTR | | 2,456,887 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP I | *W EXP 02/19/202 | G0633D125 | 211 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP II | COM CL A | G0633U101 | 14,625 | 1,500,000 | SH | | OTR | | 1,500,000 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP | *W EXP 02/19/202 | G0633U127 | 394 | 375,000 | SH | | OTR | | 375,000 | 0 | 0 |
AVANTOR INC | COM | 05352A100 | 133,545 | 3,265,151 | SH | | OTR | | 3,265,151 | 0 | 0 |
AVITA MEDICAL INC | COM | 05380C102 | 14,176 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
AVROBIO INC | COM | 05455M100 | 4,129 | 740,000 | SH | | OTR | | 740,000 | 0 | 0 |
BEAM THERAPEUTICS INC | COM | 07373V105 | 149,448 | 1,717,590 | SH | | OTR | | 1,717,590 | 0 | 0 |
BERENSON ACQUISITION CORP I | UNIT 99/99/9999 | 083690206 | 24,404 | 2,475,000 | SH | | OTR | | 2,475,000 | 0 | 0 |
BHP GROUP PLC | SPONSORED ADR | 05545E209 | 322,084 | 6,354,000 | SH | | OTR | 1 | 6,354,000 | 0 | 0 |
BIG SKY GROWTH PARTNERS INC | CLASS A COM | 08954L102 | 15,159 | 1,550,000 | SH | | OTR | | 1,550,000 | 0 | 0 |
BIG SKY GROWTH PARTNERS INC | *W EXP 04/01/202 | 08954L110 | 310 | 387,500 | SH | | OTR | | 387,500 | 0 | 0 |
BIOATLA INC | COM | 09077B104 | 5,299 | 180,000 | SH | | OTR | | 180,000 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 48,351 | 170,859 | SH | | OTR | | 170,859 | 0 | 0 |
BLACKSTONE INC | COM | 09260D107 | 309,410 | 2,659,536 | SH | | OTR | | 2,659,536 | 0 | 0 |
BLUE WHALE ACQUISITION CORP | UNIT 07/30/2026 | G1330M111 | 5,756 | 575,000 | SH | | OTR | | 575,000 | 0 | 0 |
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 97,094 | 944,403 | SH | | OTR | | 944,403 | 0 | 0 |
BOSTON SCIENTIFIC CORP | COM | 101137107 | 607,572 | 14,002,581 | SH | | OTR | | 14,002,581 | 0 | 0 |
BROADCOM INC | COM | 11135F101 | 315,447 | 650,500 | SH | | OTR | | 650,500 | 0 | 0 |
BROADMARK RLTY CAP INC | COM | 11135B100 | 48,868 | 4,956,174 | SH | | OTR | | 4,956,174 | 0 | 0 |
BROADMARK RLTY CAP INC | *W EXP 11/15/202 | 11135B118 | 861 | 7,174,613 | SH | | OTR | | 7,174,613 | 0 | 0 |
CARA THERAPEUTICS INC | COM | 140755109 | 30,900 | 2,000,000 | SH | | OTR | | 2,000,000 | 0 | 0 |
CARIBOU BIOSCIENCES INC | COM | 142038108 | 70,738 | 2,963,448 | SH | | OTR | | 2,963,448 | 0 | 0 |
CASCADE ACQUISITION CORP | COM CL A | 147151104 | 9,851 | 990,000 | SH | | OTR | | 990,000 | 0 | 0 |
CASCADE ACQUISITION CORP | *W EXP 11/30/202 | 147151112 | 307 | 495,000 | SH | | OTR | | 495,000 | 0 | 0 |
CATALENT INC | COM | 148806102 | 123,782 | 930,199 | SH | | OTR | | 930,199 | 0 | 0 |
CATALYST PARTNRS ACQUISITN C | CLASS A ORD SHS | G19550105 | 7,351 | 753,900 | SH | | OTR | | 753,900 | 0 | 0 |
CATALYST PARTNRS ACQUISITN C | *W EXP 05/12/202 | G19550121 | 128 | 150,780 | SH | | OTR | | 150,780 | 0 | 0 |
CENTENE CORP DEL | COM | 15135B101 | 284,936 | 4,572,875 | SH | | OTR | | 4,572,875 | 0 | 0 |
CF ACQUISITION CORP VI | COM CL A | 12521J103 | 971 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
CF ACQUISITION CORP VI | *W EXP 02/18/202 | 12521J111 | 20 | 25,000 | SH | | OTR | | 25,000 | 0 | 0 |
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 277,201 | 381,001 | SH | | OTR | | 381,001 | 0 | 0 |
CHEMOCENTRYX INC | COM | 16383L106 | 6,601 | 386,000 | SH | | OTR | | 386,000 | 0 | 0 |
CHURCHILL CAPITAL CORP VI | COM CL A | 17143W101 | 3,908 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
CHURCHILL CAPITAL CORP VI | *W EXP 02/17/202 | 17143W119 | 96 | 80,000 | SH | | OTR | | 80,000 | 0 | 0 |
CHURCHILL CAPITAL CORP VII | COM CL A | 17144M102 | 9,720 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
CHURCHILL CAPITAL CORP VII | *W EXP 02/29/202 | 17144M110 | 184 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
CLEVER LEAVES HOLDINGS INC | COM | 186760104 | 19,740 | 2,543,767 | SH | | OTR | | 2,543,767 | 0 | 0 |
CLOVIS ONCOLOGY INC | NOTE 1.250% 5/0 | 189464AC4 | 37,511 | 51,910,000 | PRN | | OTR | | 51,910,000 | 0 | 0 |
CM LIFE SCIENCES III INC | CLASS A COM | 125841106 | 7,440 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
CM LIFE SCIENCES III INC | *W EXP 04/30/202 | 125841114 | 321 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 5,046 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
COLONNADE ACQUISITION CORP I | SHS CL A | G2284B101 | 4,890 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
COLONNADE ACQUISITION CORP I | *W EXP 99/99/999 | G2284B119 | 81 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
CORAZON CAPITAL V838 MONOCER | CLASS A ORD SHS | G24237102 | 9,725 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
CORAZON CAPITAL V838 MONOCER | *W EXP 03/24/202 | G24237128 | 253 | 333,334 | SH | | OTR | | 333,334 | 0 | 0 |
CORSAIR PARTNERING CORP | SHS CL A | G2540H108 | 6,895 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
CORSAIR PARTNERING CORP | *W EXP 07/06/202 | G2540H116 | 177 | 233,330 | SH | | OTR | | 233,330 | 0 | 0 |
CVS HEALTH CORP | COM | 126650100 | 19,857 | 234,000 | SH | | OTR | | 234,000 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 97,669 | 2,732,775 | SH | | OTR | | 2,732,775 | 0 | 0 |
DARIOHEALTH CORP | COM NEW | 23725P209 | 7,371 | 540,000 | SH | | OTR | | 540,000 | 0 | 0 |
DECARBONIZATION PLUS ACQU II | CLASS A COM | 24279D105 | 20,100 | 2,000,000 | SH | | OTR | | 2,000,000 | 0 | 0 |
DECARBONIZATION PLUS ACQU II | *W EXP 03/19/202 | 24279D113 | 1,400 | 666,666 | SH | | OTR | | 666,666 | 0 | 0 |
DISRUPTIVE ACQUISITION CORP | CLASS A ORD SHS | G2770Y102 | 13,594 | 1,400,000 | SH | | OTR | | 1,400,000 | 0 | 0 |
DISRUPTIVE ACQUISITION CORP | *W EXP 03/06/202 | G2770Y128 | 303 | 466,667 | SH | | OTR | | 466,667 | 0 | 0 |
DRAFTKINGS INC | COM CL A | 26142R104 | 18,782 | 390,000 | SH | | OTR | 1 | 390,000 | 0 | 0 |
DRAGONEER GROWTH OPT CORP II | CL A SHS | G28315102 | 2,450 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 113,336 | 1,995,000 | SH | | OTR | | 1,995,000 | 0 | 0 |
EQUIFAX INC | COM | 294429105 | 225,945 | 891,583 | SH | | OTR | | 891,583 | 0 | 0 |
EXACT SCIENCES CORP | COM | 30063P105 | 57,041 | 597,598 | SH | | OTR | | 597,598 | 0 | 0 |
EXELIXIS INC | COM | 30161Q104 | 204,206 | 9,659,712 | SH | | OTR | | 9,659,712 | 0 | 0 |
FACEBOOK INC | CL A | 30303M102 | 361,703 | 1,065,745 | SH | | OTR | | 1,065,745 | 0 | 0 |
FATE THERAPEUTICS INC | COM | 31189P102 | 136,997 | 2,311,398 | SH | | OTR | | 2,311,398 | 0 | 0 |
FIBROGEN INC | COM | 31572Q808 | 14,780 | 1,446,212 | SH | | OTR | | 1,446,212 | 0 | 0 |
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 266,743 | 2,192,172 | SH | | OTR | | 2,192,172 | 0 | 0 |
FIFTH WALL ACQUISITN CORP III | CLASS A ORD SHS | G34142102 | 9,820 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
FINSERV ACQUISITION CORP II | COM CL A | 31809Y103 | 5,826 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
FINSERV ACQUISITION CORP II | *W EXP 02/17/202 | 31809Y111 | 133 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
FIRST RESERVE SUSTAINABLE GW | CLASS A COM | 336169107 | 3,960 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
FIRST RESERVE SUSTAINABLE GW | *W EXP 03/05/202 | 336169115 | 83 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
FIVE9 INC | COM | 338307101 | 18,530 | 116,000 | SH | | OTR | | 116,000 | 0 | 0 |
FOREST ROAD ACQUISITION COR | CL A | 34619V103 | 12,188 | 1,250,000 | SH | | OTR | | 1,250,000 | 0 | 0 |
FOREST ROAD ACQUISITION COR | *W EXP 01/15/202 | 34619V111 | 218 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
FORTRESS VALUE ACQUISI CORP | COM CL A | 34964K108 | 17,045 | 1,750,000 | SH | | OTR | | 1,750,000 | 0 | 0 |
FORTRESS VALUE ACQUISI CORP | *W EXP 03/18/202 | 34964K116 | 177 | 218,748 | SH | | OTR | | 218,748 | 0 | 0 |
FORUM MERGER IV CORP | CLASS A COM | 349875104 | 9,760 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
FORUM MERGER IV CORP | *W EXP 03/15/202 | 349875112 | 261 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 9,950 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
FTAC HERA ACQUISITION CORP | CLASS A ORD SHS | G3728Y103 | 4,870 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
FTAC HERA ACQUISITION CORP | *W EXP 02/28/202 | G3728Y111 | 129 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
FULL TRUCK ALLIANCE CO LTD | SPONSORED ADS | 35969L108 | 12,494 | 815,000 | SH | | OTR | | 815,000 | 0 | 0 |
G SQUARED ASCEND I INC | *W EXP 02/01/202 | G4204R117 | 105 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
G SQUARED ASCEND I INC | SHS CL A | G4204R109 | 4,933 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
GENERATION BIO CO | COM | 37148K100 | 87,745 | 3,500,000 | SH | | OTR | | 3,500,000 | 0 | 0 |
GOL LINHAS AEREAS INTELIGENT | SPON ADR PFD NEW | 38045R206 | 655 | 85,838 | SH | | OTR | | 85,838 | 0 | 0 |
GORES HLDGS VIII INC | CL A | 382863108 | 3,928 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
GORES HLDGS VIII INC | *W EXP 03/01/202 | 382863116 | 57 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
GORES HOLDINGS VII INC | COM CL A | 38286T101 | 7,335 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
GORES HOLDINGS VII INC | *W EXP 02/25/202 | 38286T119 | 111 | 93,750 | SH | | OTR | | 93,750 | 0 | 0 |
GORES METROPOULOS II INC | CL A | 382873107 | 10,868 | 1,100,000 | SH | | OTR | | 1,100,000 | 0 | 0 |
GORES METROPOULOS II INC | *W EXP 01/31/202 | 382873115 | 255 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
GORES TECHNOLOGY PARTNERS II | CLASS A COM | 38287L107 | 5,868 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
GORES TECHNOLOGY PARTNERS II | *W EXP 03/16/202 | 38287L115 | 134 | 120,000 | SH | | OTR | | 120,000 | 0 | 0 |
GORES TECHNOLOGY PARTNERS IN | CLASS A COM | 382870103 | 2,455 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
GORES TECHNOLOGY PARTNERS IN | *W EXP 03/16/202 | 382870111 | 56 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 776 | 53,133 | SH | | OTR | 1 | 53,133 | 0 | 0 |
GULFPORT ENERGY CORP | COMMON SHARES | 402635502 | 26,481 | 322,119 | SH | | OTR | | 322,119 | 0 | 0 |
HELLO GROUP INC | NOTE 1.250% 7/0 | 60879BAB3 | 103,660 | 123,449,000 | PRN | | OTR | | 123,449,000 | 0 | 0 |
HILTON WORLDWIDE HLDGS INC | COM | 43300A203 | 275,460 | 2,085,077 | SH | | OTR | | 2,085,077 | 0 | 0 |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 128,400 | 1,172,174 | SH | | OTR | | 1,172,174 | 0 | 0 |
HOWMET AEROSPACE INC | COM | 443201108 | 324,730 | 10,408,000 | SH | | OTR | | 10,408,000 | 0 | 0 |
HUDSON EXECUTIVE INVES III | COM CL A | 44376L107 | 2,433 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
HUDSON EXECUTIVE INVES III | *W EXP 02/22/202 | 44376L115 | 41 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
HUMANCO ACQUISITION CORP | COM CL A | 44487N109 | 5,033 | 508,900 | SH | | OTR | | 508,900 | 0 | 0 |
HUMANCO ACQUISITION CORP | *W EXP 99/99/999 | 44487N117 | 211 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
IHS MARKIT LTD | SHS | G47567105 | 60,048 | 514,900 | SH | | OTR | 1 | 514,900 | 0 | 0 |
IKENA ONCOLOGY INC | COM | 45175G108 | 22,381 | 1,117,349 | SH | | OTR | | 1,117,349 | 0 | 0 |
IMAGO BIOSCIENCES INC | COM | 45250K107 | 53,506 | 2,671,313 | SH | | OTR | | 2,671,313 | 0 | 0 |
INFLECTION POINT ACQUSTN COR | UNIT 09/21/2026 | G47874105 | 18,772 | 1,900,000 | SH | | OTR | | 1,900,000 | 0 | 0 |
INTERPRIVATE II ACQUISITION | CL A COM | 46064Q108 | 3,912 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
INTERPRIVATE II ACQUISITION | *W EXP 09/03/202 | 46064Q116 | 79 | 80,000 | SH | | OTR | | 80,000 | 0 | 0 |
INTERPRIVATE III FINANCIAL P | COM CL A | 46064R106 | 3,962 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
INTERPRIVATE III FINANCIAL P | *W EXP 99/99/999 | 46064R114 | 102 | 79,600 | SH | | OTR | | 79,600 | 0 | 0 |
INTERPRIVATE IV INFRATECH PR | CLASS A COM | 46064T102 | 5,817 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
INTERPRIVATE IV INFRATECH PR | *W EXP 03/05/202 | 46064T110 | 86 | 120,000 | SH | | OTR | | 120,000 | 0 | 0 |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 131,684 | 5,339,994 | SH | | OTR | | 5,339,994 | 0 | 0 |
IQIYI INC | NOTE 3.750%12/0 | 46267XAB4 | 134,339 | 136,177,000 | PRN | | OTR | | 136,177,000 | 0 | 0 |
IQIYI INC | NOTE 2.000% 4/0 | 46267XAD0 | 162,810 | 184,662,000 | PRN | | OTR | | 184,662,000 | 0 | 0 |
IQIYI INC | NOTE 4.000%12/1 | 46267XAE8 | 69,076 | 80,300,000 | PRN | | OTR | | 80,300,000 | 0 | 0 |
IQVIA HLDGS INC | COM | 46266C105 | 647,658 | 2,703,756 | SH | | OTR | | 2,703,756 | 0 | 0 |
JAWS MUSTANG ACQUISITION COR | SHS CL A | G50737108 | 7,808 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
JAWS MUSTANG ACQUISITION COR | *W EXP 01/30/202 | G50737124 | 230 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 74,859 | 574,907 | SH | | OTR | | 574,907 | 0 | 0 |
JOYY INC | NOTE 0.750% 6/1 | 98426TAD8 | 36,685 | 38,665,000 | PRN | | OTR | | 38,665,000 | 0 | 0 |
JOYY INC | NOTE 1.375% 6/1 | 98426TAF3 | 8,406 | 9,000,000 | PRN | | OTR | | 9,000,000 | 0 | 0 |
KARUNA THERAPEUTICS INC | COM | 48576A100 | 85,631 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
KE HLDGS INC | SPONSORED ADS | 482497104 | 4,985 | 273,000 | SH | | OTR | | 273,000 | 0 | 0 |
KENSINGTON CAPITAL ACQUISITI | UNIT 99/99/9999 | G5251K111 | 7,907 | 775,200 | SH | | OTR | | 775,200 | 0 | 0 |
KHOSLA VENTURES ACQUISITION | CL A | 482504107 | 6,909 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
KHOSLA VENTURES ACQUSTN CO II | COM CL A | 482505104 | 19,350 | 1,900,787 | SH | | OTR | | 1,900,787 | 0 | 0 |
KHOSLA VENTURES ACQUT CO III | COM CL A | 482506102 | 27,528 | 2,809,000 | SH | | OTR | | 2,809,000 | 0 | 0 |
KKR ACQUISITION HOLDING I CO | COM CLASS A | 48253T109 | 14,625 | 1,500,000 | SH | | OTR | | 1,500,000 | 0 | 0 |
KKR ACQUISITION HOLDING I CO | *W EXP 99/99/999 | 48253T117 | 360 | 375,000 | SH | | OTR | | 375,000 | 0 | 0 |
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 100,156 | 355,871 | SH | | OTR | | 355,871 | 0 | 0 |
LANDCADIA HOLDINGS IV INC | CLASS A COM | 51477A104 | 4,870 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
LANDCADIA HOLDINGS IV INC | *W EXP 03/29/202 | 51477A112 | 125 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
LAZARD GROWTH ACQUISITION CO | CL A ORD SHS | G54035103 | 2,919 | 300,000 | SH | | OTR | | 300,000 | 0 | 0 |
LAZARD GROWTH ACQUISITION CO | *W EXP 02/10/202 | G54035111 | 49 | 60,000 | SH | | OTR | | 60,000 | 0 | 0 |
LDH GROWTH CORP I | CLASS A ORD SHS | G54094100 | 1,467 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
LDH GROWTH CORP I | *W EXP 03/17/202 | G54094126 | 23 | 30,000 | SH | | OTR | | 30,000 | 0 | 0 |
LEVERE HOLDINGS CORP | CLASS A ORD SHS | G5462L106 | 7,808 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
LEVERE HOLDINGS CORP | *W EXP 03/09/202 | G5462L122 | 227 | 266,667 | SH | | OTR | | 266,667 | 0 | 0 |
LIVE OAK MOBILITY ACQUISI CO | COM CL A | 538126103 | 2,418 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
LIVE OAK MOBILITY ACQUISI CO | *W EXP 03/04/202 | 538126111 | 46 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 7,173 | 810,500 | SH | | OTR | | 810,500 | 0 | 0 |
LONGVIEW ACQUISITION CORP II | COM CL A | 54319Q105 | 3,013 | 304,698 | SH | | OTR | | 304,698 | 0 | 0 |
LONGVIEW ACQUISITION CORP II | *W EXP 99/99/999 | 54319Q113 | 79 | 60,940 | SH | | OTR | | 60,940 | 0 | 0 |
LUFAX HOLDING LTD | ADS REP SHS CL A | 54975P102 | 100,211 | 14,356,899 | SH | | OTR | | 14,356,899 | 0 | 0 |
MACQUARIE INFRASTR HOLD LLC | COMMON UNITS | 55608B105 | 176,884 | 4,361,050 | SH | | OTR | | 4,361,050 | 0 | 0 |
MASTERCARD INCORPORATED | CL A | 57636Q104 | 329,635 | 948,100 | SH | | OTR | | 948,100 | 0 | 0 |
MERCURY ECOM ACQUISITION COR | CLASS A COM | 589381102 | 16,875 | 1,732,500 | SH | | OTR | | 1,732,500 | 0 | 0 |
MERCURY ECOM ACQUISITION COR | *W EXP 07/27/202 | 589381110 | 433 | 866,250 | SH | | OTR | | 866,250 | 0 | 0 |
METALS ACQUISITION CORP | UNIT 99/99/9999 | G60405118 | 24,527 | 2,475,000 | SH | | OTR | | 2,475,000 | 0 | 0 |
MICROSOFT CORP | COM | 594918104 | 426,426 | 1,512,578 | SH | | OTR | | 1,512,578 | 0 | 0 |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 42,232 | 238,718 | SH | | OTR | | 238,718 | 0 | 0 |
NATERA INC | COM | 632307104 | 144,887 | 1,300,134 | SH | | OTR | | 1,300,134 | 0 | 0 |
NEOGENOMICS INC | COM NEW | 64049M209 | 25,559 | 529,839 | SH | | OTR | | 529,839 | 0 | 0 |
NEW ORIENTAL ED & TECHNOLOGY | SPON ADR | 647581107 | 267 | 130,000 | SH | | OTR | | 130,000 | 0 | 0 |
NEW YORK TIMES CO | CL A | 650111107 | 400,873 | 8,136,258 | SH | | OTR | | 8,136,258 | 0 | 0 |
NEXTGEN ACQUISITION CORP II | CLASS A ORD SHS | G65317102 | 5,460 | 550,914 | SH | | OTR | | 550,914 | 0 | 0 |
NIGHTDRAGON ACQUISITION CORP | CLASS A COM | 65413D105 | 3,908 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
NIGHTDRAGON ACQUISITION CORP | *W EXP 02/26/202 | 65413D113 | 68 | 80,000 | SH | | OTR | | 80,000 | 0 | 0 |
NORTHERN GENESIS ACQUISITION | COMMON STOCK | 66516U101 | 2,761 | 278,026 | SH | | OTR | | 278,026 | 0 | 0 |
NORTHERN STAR INVEST CORP III | COM CL A | 66574L100 | 974 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
NORTHERN STAR INVEST CORP III | *W EXP 02/25/202 | 66574L118 | 17 | 16,667 | SH | | OTR | | 16,667 | 0 | 0 |
NORTHERN STAR INVEST CORP IV | COM CL A | 66575B101 | 980 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
NORTHERN STAR INVEST CORP IV | *W EXP 02/25/202 | 66575B119 | 15 | 16,666 | SH | | OTR | | 16,666 | 0 | 0 |
NOVAVAX INC | COM NEW | 670002401 | 17,355 | 83,713 | SH | | OTR | | 83,713 | 0 | 0 |
NOVUS CAPITAL CORPORATION II | COM CL A | 67012W104 | 7,033 | 710,451 | SH | | OTR | | 710,451 | 0 | 0 |
NOVUS CAPITAL CORPORATION II | *W EXP 02/02/202 | 67012W112 | 254 | 233,333 | SH | | OTR | | 233,333 | 0 | 0 |
NUVATION BIO INC | COM CL A | 67080N101 | 21,967 | 2,210,000 | SH | | OTR | | 2,210,000 | 0 | 0 |
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 1,530 | 665,200 | SH | | OTR | | 665,200 | 0 | 0 |
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 50,902 | 1,992,250 | SH | | OTR | | 1,992,250 | 0 | 0 |
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 7,313 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
PATHFINDER ACQUISITION CORP | CL A | G04119106 | 7,410 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
PATHFINDER ACQUISITION CORP | *W EXP 02/19/202 | G04119122 | 142 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
PERSHING SQUARE TONTINE HLDG | COM CL A | 71531R109 | 19,700 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
PFIZER INC | COM | 717081103 | 43,010 | 1,000,000 | SH | Call | OTR | | 1,000,000 | 0 | 0 |
PG&E CORP | COM | 69331C108 | 70,004 | 7,292,042 | SH | | OTR | | 7,292,042 | 0 | 0 |
PLAYA HOTELS & RESORTS NV | SHS | N70544106 | 69,243 | 8,352,553 | SH | | OTR | | 8,352,553 | 0 | 0 |
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 17,610 | 2,290,000 | SH | | OTR | | 2,290,000 | 0 | 0 |
POST HOLDINGS PARTNERING COR | COM SER A | 737465104 | 7,712 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
POST HOLDINGS PARTNERING COR | *W EXP 04/12/202 | 737465112 | 240 | 266,666 | SH | | OTR | | 266,666 | 0 | 0 |
PRIVETERRA ACQUISITION CORP | CL A | 74275N102 | 1,463 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
PRIVETERRA ACQUISITION CORP | *W EXP 02/28/202 | 74275N110 | 29 | 49,995 | SH | | OTR | | 49,995 | 0 | 0 |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 42,386 | 2,392,000 | SH | | OTR | | 2,392,000 | 0 | 0 |
QIAGEN NV | SHS NEW | N72482123 | 76,168 | 1,473,848 | SH | | OTR | | 1,473,848 | 0 | 0 |
QUANTERIX CORP | COM | 74766Q101 | 27,136 | 545,000 | SH | | OTR | | 545,000 | 0 | 0 |
QUANTUM SI INC | COM CL A | 74765K105 | 8,340 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
RADIUS HEALTH INC | COM NEW | 750469207 | 26,153 | 2,107,400 | SH | | OTR | | 2,107,400 | 0 | 0 |
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 5,998 | 6,783,000 | PRN | | OTR | | 6,783,000 | 0 | 0 |
RAYTHEON TECHNOLOGIES CORP | COM | 75513E101 | 448,280 | 5,214,986 | SH | | OTR | | 5,214,986 | 0 | 0 |
READY CAPITAL CORP | COM | 75574U101 | 18,041 | 1,250,226 | SH | | OTR | | 1,250,226 | 0 | 0 |
REINVENT TECHNOLOGY PARTNERS | CLASS A ORD SHS | G7484L106 | 7,448 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
REINVENT TECHNOLOGY PARTNERS | *W EXP 03/12/202 | G7484L122 | 141 | 93,750 | SH | | OTR | | 93,750 | 0 | 0 |
REPLIGEN CORP | COM | 759916109 | 26,318 | 91,070 | SH | | OTR | | 91,070 | 0 | 0 |
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 7,316 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 76155Y108 | 19,460 | 2,000,000 | SH | | OTR | | 2,000,000 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | *W EXP 12/31/202 | 76155Y116 | 371 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
REVOLUTION MEDICINES INC | COM | 76155X100 | 75,653 | 2,750,000 | SH | | OTR | | 2,750,000 | 0 | 0 |
ROCKET INTERNET GRWT OPRT CO | SHS CL A | G7613T103 | 4,885 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
ROCKET INTERNET GRWT OPRT CO | *W EXP 99/99/999 | G7613T129 | 106 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
RXR ACQUISITION CORP | CLASS A COM | 74981W107 | 5,832 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
RXR ACQUISITION CORP | *W EXP 03/08/202 | 74981W115 | 90 | 120,000 | SH | | OTR | | 120,000 | 0 | 0 |
SALESFORCE COM INC | COM | 79466L302 | 427,962 | 1,577,915 | SH | | OTR | | 1,577,915 | 0 | 0 |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 14,982 | 162,000 | SH | | OTR | | 162,000 | 0 | 0 |
SAVARA INC | COM | 805111101 | 8,987 | 6,512,086 | SH | | OTR | | 6,512,086 | 0 | 0 |
SCION TECH GROWTH II | CL A SHS | G31070108 | 4,388 | 450,000 | SH | | OTR | | 450,000 | 0 | 0 |
SCION TECH GROWTH II | *W EXP 01/28/202 | G31070116 | 101 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
SERVICENOW INC | COM | 81762P102 | 308,833 | 496,300 | SH | | OTR | | 496,300 | 0 | 0 |
SHELTER ACQUISITION CORP I | CLASS A COM | 822821104 | 16,038 | 1,650,000 | SH | | OTR | | 1,650,000 | 0 | 0 |
SHELTER ACQUISITION CORP I | *W EXP 02/25/202 | 822821112 | 412 | 825,000 | SH | | OTR | | 825,000 | 0 | 0 |
SHERWIN WILLIAMS CO | COM | 824348106 | 271,301 | 969,868 | SH | | OTR | | 969,868 | 0 | 0 |
SLAM CORP | CL A SHS | G8210L105 | 687 | 70,508 | SH | | OTR | | 70,508 | 0 | 0 |
SLAM CORP | *W EXP 02/23/202 | G8210L121 | 16 | 17,627 | SH | | OTR | | 17,627 | 0 | 0 |
SOCIAL LEVERAGE ACQUISN CORP | COM CL A | 83363K102 | 7,335 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
SOCIAL LEVERAGE ACQUISN CORP | *W EXP 02/17/202 | 83363K110 | 156 | 187,500 | SH | | OTR | | 187,500 | 0 | 0 |
SOMALOGIC INC | CLASS A COM | 83444K105 | 72,190 | 5,826,473 | SH | | OTR | | 5,826,473 | 0 | 0 |
SPARTAN ACQUISITION CORP III | COM CL A | 84677R106 | 593 | 60,053 | SH | | OTR | | 60,053 | 0 | 0 |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 1,158,678 | 2,700,000 | SH | Call | OTR | | 2,700,000 | 0 | 0 |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 1,611,850 | 3,756,000 | SH | Put | OTR | | 3,756,000 | 0 | 0 |
SUPERNOVA PARTN ACQ CO III L | SHS CL A | G8T90F102 | 6,797 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
SUPERNOVA PARTN ACQ CO III L | *W EXP 99/99/999 | G8T90F128 | 129 | 140,000 | SH | | OTR | | 140,000 | 0 | 0 |
SUPERNOVA PARTNERS ACQUISTN | SHS CL A | G8T86C105 | 1,944 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
SUPERNOVA PARTNERS ACQUISTN | *W EXP 99/99/999 | G8T86C121 | 40 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
SURFACE ONCOLOGY INC | COM | 86877M209 | 7,570 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
SVF INVESTMENT CORP | CL A SHS | G8601L102 | 2,440 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
SVF INVESTMENT CORP | *W EXP 12/20/202 | G8601L128 | 50 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
TAILWIND TWO ACQUISITION COR | SHS CL A | G86613109 | 9,730 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
TAILWIND TWO ACQUISITION COR | *W EXP 03/09/202 | G86613125 | 330 | 333,333 | SH | | OTR | | 333,333 | 0 | 0 |
TANGO THERAPEUTICS INC | COM | 87583X109 | 3,879 | 300,000 | SH | | OTR | | 300,000 | 0 | 0 |
TCV ACQUISITION CORP | CL A SHS | G8704C124 | 4,900 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
THE MUSIC ACQUISITION CORP | COM CLASS A | 62752R100 | 1,216 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
THE MUSIC ACQUISITION CORP | *W EXP 02/05/202 | 62752R118 | 47 | 62,500 | SH | | OTR | | 62,500 | 0 | 0 |
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 559,709 | 979,659 | SH | | OTR | | 979,659 | 0 | 0 |
THUNDER BRIDGE CAP PRTNRS III | COM CL A | 88605T100 | 7,320 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
THUNDER BRIDGE CAP PRTNRS III | *W EXP 02/15/202 | 88605T118 | 113 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
TIGA ACQUISITION CORP | SHS CL A | G88672103 | 10,940 | 1,080,000 | SH | | OTR | | 1,080,000 | 0 | 0 |
TIGA ACQUISITION CORP | *W EXP 11/06/202 | G88672111 | 378 | 540,000 | SH | | OTR | | 540,000 | 0 | 0 |
TIO TECH A | CLASS A ORD SHS | G8T10C106 | 4,845 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
TIO TECH A | *W EXP 04/12/202 | G8T10C114 | 126 | 166,666 | SH | | OTR | | 166,666 | 0 | 0 |
T-MOBILE US INC | COM | 872590104 | 587,570 | 4,599,011 | SH | | OTR | | 4,599,011 | 0 | 0 |
TPG PACE BENEFICIAL II CORP | COMMON STOCK | G89826104 | 7,361 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
TPG PACE SOLUTIONS CORP | SHS CL A | G8656V104 | 3,518 | 350,000 | SH | | OTR | | 350,000 | 0 | 0 |
TRANSUNION | COM | 89400J107 | 228,212 | 2,031,982 | SH | | OTR | | 2,031,982 | 0 | 0 |
UNIQURE NV | SHS | N90064101 | 9,603 | 300,000 | SH | | OTR | | 300,000 | 0 | 0 |
VECTOR ACQUISITION CORP II | CL A SHS | G9460A104 | 7,313 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
VERACYTE INC | COM | 92337F107 | 8,604 | 185,222 | SH | | OTR | | 185,222 | 0 | 0 |
VIRGIN GROUP ACQUISIT CORP I | SHS CL A | G9460K102 | 9,710 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
VIRGIN GROUP ACQUISIT CORP I | *W EXP 03/13/202 | G9460K128 | 172 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
VISA INC | COM CL A | 92826C839 | 276,991 | 1,243,504 | SH | | OTR | | 1,243,504 | 0 | 0 |
VPC IMPACT ACQU HOLDI III IN | COM CL A | 91835J108 | 5,946 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
VPC IMPACT ACQU HOLDI III IN | *W EXP 09/03/202 | 91835J116 | 170 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
VPC IMPACT ACQUISITION HLDG II | CLASS A ORD | G9460L126 | 4,186 | 425,000 | SH | | OTR | | 425,000 | 0 | 0 |
VPC IMPACT ACQUISITION HLDG II | *W EXP 03/05/202 | G9460L118 | 128 | 106,250 | SH | | OTR | | 106,250 | 0 | 0 |
WABTEC | COM | 929740108 | 512,531 | 5,945,151 | SH | | OTR | | 5,945,151 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I B | SHS CL A | G9460M108 | 7,335 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I A | SHS CL A | G9461D107 | 7,365 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I | *W EXP 99/99/999 | G9461D115 | 167 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I | *W EXP 99/99/999 | G9460M124 | 140 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
WILLIS TOWERS WATSON PLC LTD | SHS | G96629103 | 319,168 | 1,373,000 | SH | | OTR | 1 | 1,373,000 | 0 | 0 |
ZEALAND PHARMA A/S | SPONSORED ADR | 98920Y304 | 14,306 | 510,000 | SH | | OTR | | 510,000 | 0 | 0 |
ZOGENIX INC | COM NEW | 98978L204 | 42,030 | 2,766,935 | SH | | OTR | | 2,766,935 | 0 | 0 |